Abstract

In the 1960s it was shown that a rare type of tumour called a teratocarcinoma contains cells that are both pluripotent and self‐renewing (Kleinsmith & Pierce, 1964). Pluripotent means the capacity of an individual cell to give rise to all other cell types of the body and the germline. This property is normally restricted to a brief window in early development. Self‐renewal is the production of identical daughter cells while retaining the ability for differentiation. It is the defining feature of a stem cell. The study of teratocarcinoma stem cells led to particular culture conditions that allowed them to be propagated ex vivo without differentiation. In 1981 Martin Evans, Matt Kaufman and Gail Martin found that cells from early mouse embryos exposed to the same culture environment can suspend developmental progression and continue to multiply while remaining pluripotent (Evans & Kaufman, 1981; Martin, 1981). These are embryonic stem (ES) cells. I was completing my undergraduate studies in Oxford at that time and was fortunate to learn about this rather esoteric research from a wonderful teacher, Chris Graham. Chris also talked about parallel discoveries of growth factors and the provocative idea that they might regulate cell fate. I was captivated by the idea of understanding and controlling the pluripotent state » I was captivated by the idea of understanding and controlling the pluripotent state. « and that has been my obsession ever since. I went to Edinburgh to do a PhD on teratocarcinoma stem cells with Martin Hooper. There I was struck by an observation by a previous PhD student that the requirement of the stem cells for co‐culture with a feeder layer could be replaced for a short time by conditioned medium. To me this meant only one thing; a growth factor that could block differentiation. This was not …

Highlights

  • In the 1960s it was shown that a rare type of tumour called a teratocarcinoma contains cells that are both pluripotent and self-renewing (Kleinsmith & Pierce, 1964)

  • I thought the factor might be insulin-like growth factor (IGF) but as growth factors were not available in catalogues in those days I had to use a cell culture supernatant as a source for them

  • We were lucky; differentiation inhibiting activity (DIA) was active in a particular proliferative assay that had just been used to clone the cytokine we know as leukaemia inhibitory factor (LIF)

Read more

Summary

Finding the differentiation inhibiting activity

I went to Edinburgh to do a PhD on teratocarcinoma stem cells with Martin Hooper. There I was struck by an observation by a previous PhD student that the requirement of the stem cells for co-culture with a feeder layer could be replaced for a short time by conditioned medium. To me this meant only one thing; a growth factor that could block differentiation. I brought Martin to the microscope and he just said ‘They’re beautiful!’ They were; for the first time totally undifferentiated colonies without feeders. The field has grown enormously and the biomedical opportunities are thrilling, my group still mainly studies the fundamental biology of pluripotent stem cells and the decision between self-renewal and commitment

Understanding pluripotency
The medical possibilities of pluripotent cells
Austin Smith
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call